These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23999711

  • 21. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of IgG antibody levels to Clostridium botulinum antigens between euthanased and surviving cases of chronic grass sickness.
    Nunn FG, Pirie RS, McGorum B, Wernery U, Poxton IR.
    Res Vet Sci; 2007 Aug 01; 83(1):82-4. PubMed ID: 17156804
    [Abstract] [Full Text] [Related]

  • 24. Progress in cell based assays for botulinum neurotoxin detection.
    Pellett S.
    Curr Top Microbiol Immunol; 2013 Aug 01; 364():257-85. PubMed ID: 23239357
    [Abstract] [Full Text] [Related]

  • 25. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Protein Pept Lett; 2017 Aug 01; 24(6):495-502. PubMed ID: 28260503
    [Abstract] [Full Text] [Related]

  • 26. Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant H(C) and H(N) fragments from Clostridium botulinum neurotoxin types C(1) and D.
    Curran RM, Fringuelli E, Graham D, Elliott CT.
    Vet Immunol Immunopathol; 2009 Jul 15; 130(1-2):1-10. PubMed ID: 19233482
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E.
    Mansour AA, Mousavi SL, Rasooli I, Nazarian S, Amani J, Farhadi N.
    Biologicals; 2010 Mar 15; 38(2):260-4. PubMed ID: 19879159
    [Abstract] [Full Text] [Related]

  • 33. Expression, purification, and characterization of Clostridium botulinum type B light chain.
    Gilsdorf J, Gul N, Smith LA.
    Protein Expr Purif; 2006 Apr 15; 46(2):256-67. PubMed ID: 16297638
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.
    Suzuki T, Nagano T, Niwa K, Uchino M, Tomizawa M, Sagane Y, Watanabe T.
    Curr Microbiol; 2017 Jan 15; 74(1):49-54. PubMed ID: 27785552
    [Abstract] [Full Text] [Related]

  • 36. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastoris.
    Dux MP, Huang J, Barent R, Inan M, Swanson ST, Sinha J, Ross JT, Smith LA, Smith TJ, Henderson I, Meagher MM.
    Protein Expr Purif; 2011 Feb 15; 75(2):177-85. PubMed ID: 20933089
    [Abstract] [Full Text] [Related]

  • 37. Effect of adjuvants on antibody titer of synthetic recombinant light chain of botulinum neurotoxin type B and its diagnostic potential for botulism.
    Jain S, Ponmariappan S, Kumar O, Singh L.
    J Microbiol Biotechnol; 2011 Jul 15; 21(7):719-27. PubMed ID: 21791958
    [Abstract] [Full Text] [Related]

  • 38. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A, Alam SI, Dhaked RK, Singh L.
    Indian J Med Res; 2006 Sep 15; 124(3):355-62. PubMed ID: 17085839
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate.
    Ben David A, Torgeman A, Barnea A, Zichel R.
    Protein Expr Purif; 2015 Jun 15; 110():122-9. PubMed ID: 25727047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.